Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation

被引：0
|
作者：
Alfaro, E. [1 ]
Diaz-Garcia, E. [2 ]
Garcia-Tovar, S. [1 ]
Zamarron, E. [3 ]
Mangas, A. [4 ]
Galera, R. [4 ]
Ruiz-Hernandez, J. [5 ]
Sole-Violan, J. [5 ]
Rodriguez-Gallego, C. [5 ]
Van-Den-Rym, A. [6 ]
Perez-De-Diego, R. [6 ]
Nanwani-Nanwani, K. [7 ]
Lopez-Collazo, E.
Garcia-Rio, F. [4 ]
Cubillos, C. [8 ]
机构：
[1] Univ Paz, Grp Enfermedades Resp, Inst Invest, Biomed Hosp, Madrid, Spain
[2] CIBERES, Grp Enfermedades Resp, Madrid, Spain
[3] Hosp Univ La Paz, Dept Neumologia, Madrid, Spain
[4] Hosp Univ La Paz, Dpto Neumol, Madrid, Spain
[5] Hosp Univ Dr Negrin, Dpto Inmunol, Las Palmas Gran Canaria, Spain
[6] Univ La Paz, Lab Immunogenet Human Dis, Inst Invest, Biomed Hosp, Madrid, Spain
[7] Hosp Univ La Paz, Dpto Med Intensiva, Madrid, Spain
[8] Univ La Paz, Grp Respuesta Inmune Innata, Inst Invest, Biomed Hosp, Madrid, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2747
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease
    Kudryavtsev, Igor
    Serebriakova, Maria
    Zhiduleva, Ekaterina
    Murtazalieva, Patimat
    Titov, Vladislav
    Malashicheva, Anna
    Shishkova, Anastasya
    Semenova, Daria
    Irtyuga, Olga
    Isakov, Dmitry
    Mitrofanova, Lubov
    Moiseeva, Olga
    Golovkin, Alexey
    FRONTIERS IN GENETICS, 2019, 10
  • [32] Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3
    Fausther, Michel
    Pelletier, Julie
    Ribeiro, Carla M.
    Sevigny, Jean
    Picher, Maryse
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2010, 298 (06) : L804 - L818
  • [33] Hyperlipidemia and Obesity's Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection
    Khatchadourian, Christopher
    Sisliyan, Christina
    Nguyen, Kevin
    Poladian, Nicole
    Tian, Qi
    Tamjidi, Faraaz
    Luong, Bao
    Singh, Manpreet
    Robison, Jeremiah
    Venketaraman, Vishwanath
    CLINICS AND PRACTICE, 2021, 11 (04) : 694 - 707
  • [34] The role of ectonucleotidases CD39 and CD73 and adenosine signaling in solid organ transplantation
    Roberts, Veena
    Stagg, John
    Dwyer, Karen M.
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [35] CD39: a regulatory role in childhood arthritis
    H Moncrieffe
    K Nistala
    P Hunter
    Y Kamhieh
    L Wedderburn
    Pediatric Rheumatology, 6 (Suppl 1)
  • [36] COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations
    Levy, Jerrold H.
    Iba, Toshiaki
    Olson, Lyra B.
    Corey, Kristen M.
    Ghadimi, Kamrouz
    Connors, Jean M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 : 29 - 35
  • [37] NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
    Lazar, Zsofia
    Muellner, Nina
    Lucattelli, Monica
    Ayata, Cemil Korcan
    Cicko, Sanja
    Yegutkin, Gennady G.
    De Cunto, Giovanna
    Mueller, Tobias
    Meyer, Anja
    Hossfeld, Madelon
    Sorichter, Stephan
    Horvath, Ildiko
    Virchow, Christian J.
    Robson, Simon C.
    Lungarella, Giuseppe
    Idzko, Marco
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) : 254 - 263
  • [38] Leukoregulatory role of CD39 in ischemic vessels
    Fujita, T
    Maliszewski, CR
    Liao, H
    Okada, K
    Marcus, AJ
    Broekman, MJ
    Ramasamy, R
    Pinsky, DJ
    CIRCULATION, 2001, 104 (17) : 274 - 274
  • [39] Phosphatidylserine is an overlooked mediator of COVID-19 thromboinflammation
    Lind, Stuart E.
    HELIYON, 2021, 7 (01)
  • [40] SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19
    Aktar, Salma
    Amin, Saiful
    VIRUS RESEARCH, 2023, 323
12345